Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Manhua Chen"'
Autor:
Xueyuan Guo, Juan Du, Yang Yang, Mingxing Wu, Wenchao Ou, Xuebin Han, Zhifang Wang, Jing Jin, Ping Zhang, Zheng Zhang, Guoqin Chen, Mingzhi Long, Guotian Yin, Tong Liu, Xiaoyan Wang, Dongsheng Li, Manhua Chen, Yugang Dong, Chunlin Lai, Xuelian Zhang, Yuan Yi, Jing Xiang, Cathy Chen, Martin Unverdorben, Changsheng Ma, ETNA-AF-China Investigators
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-15 (2024)
Abstract Real-world data on effectiveness and safety of a single non-vitamin K antagonist oral anticoagulant in the Chinese population with atrial fibrillation (AF) are limited. This study reports characteristics of patients treated with edoxaban and
Externí odkaz:
https://doaj.org/article/13319f82eba14efaa41d86869561b14f
Autor:
Lang Jiang, Jing Zhao, Qin Yang, Mei Li, Hao Liu, Xiaoyue Xiao, Song Tian, Sha Hu, Zhen Liu, Peiwen Yang, Manhua Chen, Ping Ye, Jiahong Xia
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-16 (2023)
Abstract Non-alcoholic steatohepatitis (NASH) has received great attention due to its high incidence. Here, we show that lysosomal-associated protein transmembrane 5 (LAPTM5) is associated with NASH progression through extensive bioinformatical analy
Externí odkaz:
https://doaj.org/article/406b012ceec944799adcb92caf83bb9f
Autor:
Dashuai Wang, Xiaerzhati Abuduaini, Xiaofan Huang, Hongfei Wang, Xing Chen, Sheng Le, Manhua Chen, Xinling Du
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 17, Iss 1, Pp 1-11 (2022)
Abstract Background Pneumonia is a common complication after Stanford type A acute aortic dissection surgery (AADS) and contributes significantly to morbidity, mortality, and length of stay. The purpose of this study was to identify independent risk
Externí odkaz:
https://doaj.org/article/ee1a3dfae3f74ee5bc07512d28615f76
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/31b75211b68f473d9ea0eeea94df92df
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Objective: Accumulating evidence suggested that resveratrol (RES) could protect against adverse cardiac remodeling induced by several cardiovascular diseases. However, the role of RES in the setting of heart failure with preserved ejection fraction (
Externí odkaz:
https://doaj.org/article/3aaf300bb9d842a98b2b7135622ac103
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 4 (2021)
Background Heart pathological hypertrophy has been recognized as a predisposing risk factor for heart failure and arrhythmia. DUSP (dual‐specificity phosphatase) 26 is a member of the DUSP family of proteins, which has a significant effect on nonal
Externí odkaz:
https://doaj.org/article/b9613b226d6e459489fa358f3beb8c2f
Autor:
Peng Deng, Ling Chen, Zheng Liu, Ping Ye, Sihua Wang, Jie Wu, Yufeng Yao, Yuan Sun, Xiaofan Huang, Linyun Ren, Anchen Zhang, Ke Wang, Chuangyan Wu, Zhang Yue, Xuezeng Xu, Manhua Chen
Publikováno v:
Cellular Physiology and Biochemistry, Vol 38, Iss 6, Pp 2103-2122 (2016)
Background/Aims: Cardiac fibrosis is the primary cause of deteriorated cardiac function in various cardiovascular diseases. Numerous studies have demonstrated that microRNAs (miRNAs) are critical regulators of myocardial fibrosis. Specifically, many
Externí odkaz:
https://doaj.org/article/b5df01d8529546e9995dc3fe10d3df54
Autor:
Mei Xiang, Hongbo Luo, Jia Wu, Lingyun Ren, Xiangchao Ding, Chuangyan Wu, Jiuling Chen, Shanshan Chen, Hao Zhang, Lu Yu, Yanqiang Zou, Heng Xu, Ping Ye, Manhua Chen, Jiahong Xia
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 18 (2018)
Background Cardiac hypertrophy has been recognized as an important independent risk factor for the development of heart failure and increases the risk of cardiac morbidity and mortality. A disintegrin and metalloprotease 23 (ADAM23), a member of ADAM
Externí odkaz:
https://doaj.org/article/327ff139196d4b7ea06e06c49150882b
Autor:
Lingyun Ren, Chuangyan Wu, Kai Yang, Shanshan Chen, Ping Ye, Jie Wu, Anchen Zhang, Xiaofan Huang, Ke Wang, Peng Deng, Xiangchao Ding, Manhua Chen, Jiahong Xia
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 2 (2018)
BackgroundSevere cardiac hypertrophy can lead to cardiac remodeling and even heart failure in the end, which is a leading cause of cardiovascular disease–related mortality worldwide. A disintegrin and metalloprotease‐22 (ADAM22), a member of the
Externí odkaz:
https://doaj.org/article/d2dea54cc7cc4a7ba4916f5ce9b03b01
Publikováno v:
Journal of Diabetes Research, Vol 2016 (2016)
Metformin is a first-line drug for the management of type 2 diabetes. Recent studies suggested cardioprotective effects of metformin against ischemia/reperfusion injury. However, it remains elusive whether metformin provides direct protection against
Externí odkaz:
https://doaj.org/article/f1a122f1e47e4eaebb836a948d3e325e